Start your day with a light meal, unless your doctor has said otherwise. Be sure to dress comfortably and wear something that ...

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...

Lack of OB/GYN care for hyperemesis gravidarum drives pregnant patients to IV spas offering treatment. Experts warn that ...

An offshore trial has found a link between kidney malfunction and Alzheimer's, while a local biotech legend takes a different ...

The Elliot family feels like a weight has been lifted off their shoulders after receiving a letter that their son’s life-saving infusion will be covered by insurance.

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

Eisai has submitted a new drug application to Japan’s PMDA seeking approval for Leqembi’s SC formulation, SC-AI, for early ...

To celebrate a year in business, the owners of intravenous vitamin infusion business The Dripbar are offering free shots ...

The family’s insurance company, Blue Cross Blue Shield of Oklahoma, denied coverage of Adam’s Intravenous Immunoglobulin, or ...

CliniExperts Research Services Pvt. Ltd., New Delhi, India proudly announces the successful completion of Phase IV study on Akynzeo I.V for Glenmark Pharmaceuticals ltd. As a CRO, CliniExperts ...

Five years ago this month, in November 2020, medical history was made at London-based contract research organisation, Richmond Pharmacology, when a patient received the first CRISPR therapy delivered ...